STREMBLE VENTURES LTD

Their core work

Stremble Ventures is a Cypriot technology SME that brings advanced data analytics and risk assessment capabilities to complex multi-disciplinary research challenges. In border security, they contributed expertise in risk-based profiling and anti-hacking cloud architecture; in health research, they shifted toward clinical data stratification and patient risk modeling for cardio-oncology and multimorbid elderly populations. Their work pattern suggests a company whose core competency — algorithmic risk scoring and secure data handling — travels across domains rather than being tied to a single industry. They operate exclusively as a consortium partner, contributing specialized technical components within larger pan-European research efforts.

What they specialise in

How they've shifted over time

From 2016 to 2019, Stremble operated in the security and border management space, contributing risk-based screening logic, behavioural deception detection, and cloud security architecture to the iBorderCtrl project. By 2021, their focus had shifted entirely to clinical health — specifically cardio-oncology risk in elderly patients — bringing stratification and biomarker-based assessment methods that echo their earlier risk profiling work. The consistent thread is risk quantification and data-driven classification; what changed is the application domain, from border security to patient outcomes.

Stremble appears to be repositioning from security-sector research toward health data analytics, making them a candidate partner for future projects combining clinical risk modelling, patient data platforms, or AI-assisted diagnosis — provided CARDIOCARE delivers results through 2026.

How they like to work

Stremble has never led a project — both participations are as consortium partner, suggesting they prefer or are structured to contribute specialist components rather than manage large multi-partner efforts. With 24 unique partners across 14 countries from just two projects, they work inside large, diverse consortia rather than tight bilateral collaborations. This profile fits a technology provider that plugs into bigger research structures and delivers a defined technical work package.

Despite only two projects, Stremble has built connections with 24 distinct partners across 14 countries, indicating participation in large multi-stakeholder consortia with broad European coverage. No geographic concentration is apparent from the available data.

What sets them apart

Stremble is unusual among health-sector SMEs in that their background includes security and adversarial data environments — experience with anti-hacking infrastructure and behavioural anomaly detection is rare in clinical research consortia. This cross-domain history could make them valuable in health projects where data security, patient privacy architecture, or risk-scoring methodology needs a technically rigorous partner. They are a small, agile Cypriot company with a demonstrated ability to operate inside complex pan-European RIA projects.

Highlights from their portfolio

• CARDIOCARE
  Their largest grant (EUR 652,500), running to 2026, tackles the clinically urgent intersection of breast cancer therapy and heart damage in elderly patients — a high-impact area drawing growing EU health research funding.
• iBorderCtrl
  A high-profile and controversial EU border AI project involving deception detection at checkpoints — participation signals early-mover experience in applied AI for security screening.